Abstract
The objective of this study was to analyze the expression of cysteinyl leukotriene 1 (CysLT1) receptor and glucocorticoid receptors (GRs) in nasal polyps, and to evaluate the relationship between the expression of CysLT1 receptors and that of GRs. Nasal polyps were taken from 32 patients of chronic rhinosinusitis with nasal polyposis. Samples of middle turbinate from seven healthy subjects were used as controls. Specimens were immunohistochemically stained for CysLT1 receptor, GR-α and GR-β receptor, and were quantified in the unit area of the tissues. Numbers of CysLT1 receptor-positive cells were much increased in nasal polyps than in middle turbinate (281 ± 67 vs. 157 ± 85 cells/mm2, P = .01). There was no significant difference in the numbers of GR-α positive cells between nasal polyps and normal turbinate mucosa. GR-β positive cells were increased in nasal polyps as compared to normal turbinate mucosa (36 ± 8 vs. 19 ± 7 cells/mm2, P = .03). A significant relationship was found between the expression of CysLT1 receptor and GR-β in nasal polyps (R = .525, P = .04), whereas there was no significant relationship between the expression of CysLT1 receptor and GR-α in nasal polyps. Our study shows that CysLT1 receptor expression predominates on GR-β over-expressed polyps. This may suggest the additional effect of CysLT1 receptor antagonist for the treatment of nasal polyposis resistant to steroid alone.
Similar content being viewed by others
References
Mygind N (1990) Nasal polyposis. J Allergy Clin Immunol 86:827–829
Hamilos DL, Leung DY, Muro S et al (2001) GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone. J Allergy Clin Immunol 108:59–68
Wang M, Shi P, Chen B, Shi G, Li H, Wang H (2011) Superantigen-induced glucocorticoid insensitivity in the recurrence of chronic rhinosinusitis with nasal polyps. Otolaryngol Head Neck Surg 145:717–722
Christodoulopoulos P, Cameron L, Durham S, Hamid Q (2000) Molecular pathology of allergic disease II: upper airway disease. J Allergy Clin Immunol 105:211–223
Currie GP, Lee DK, Srivastava P (2005) Long-acting bronchodilator or leukotriene modifier as add-on therapy to inhaled corticosteroids in persistent asthma? Chest 128:2954–2962
Ducharme FM (2011) Leukotriene receptor antagonists as first line or add-on treatment for asthma. BMJ 13:343
Nagata M, Saito K (2003) The roles of cysteinyl leukotrienes in eosinophilic inflammation of asthmatic airways. Int Arch Allergy Immunol 131:7–10
Chao SS, Graham SM, Brown CL, Kline JN, Hussain I (2006) Cysteinyl leukotriene 1 receptor expression in nasal polyps. Ann Otol Rhinol Laryngol 115:394–397
Rasp G (2010) Is there a role for leukotriene antagonists in the prevention of recurrent nasal polyps? Curr Opin Allergy Clin Immunol 10:200–205
Hui Y, Funk CD (2002) Cysteinyl leukotriene receptors. Biochem Pharmacol 64:1549–1557
Lund VJ, Mackay IS (1993) Staging in rhinosinusitis. Rhinology 31:183–184
Goleva E, Li LB, Eves PT, Strand MJ, Martin RJ, Leung DY (2006) Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 173:607–616
Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH (2002) Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 347:1524–1526
Shirasaki H, Kanaizumi E, Watanabe K et al (2002) Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa. Clin Exp Allergy 32:1007–1012
Adamusiak AM, Stasikowska-Kanicka O, Lewandowska-Polak A et al (2011) Expression of arachidonate metabolism enzymes and receptors in nasal polyps of aspirin-hypersensitive asthmatics. Int Arch Allergy Immunol 157:354–362
Oakley RH, Jewell CM, Yudt MR, Bofetiado DM, Cidlowski JA (1999) The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J Biol Chem 274:27857–27866
Pujols L, Mullol J, Benítez P et al (2003) Expression of the glucocorticoid receptor alpha and beta isoforms in human nasal mucosa and polyp epithelial cells. Respir Med 97:90–96
Fakhri S, Tulic M, Christodoulopoulos P et al (2004) Microbial superantigens induce glucocorticoid receptor beta and steroid resistance in a nasal explant model. Laryngoscope 114:887–892
de Wang Y (2008) Significance of susceptible gene expression profiles in nasal polyposis. Clin Exp Otorhinolaryngol 1:177–183
Hamid QA, Wenzel SE, Hauk PJ et al (1999) Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 159:1600–1604
Sousa AR, Lane SJ, Cidlowski JA, Staynov DZ, Lee TH (2000) Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor b-isoform. J Allergy Clin Immunol 105:943–950
Honda M, Orii F, Ayabe T et al (2000) Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 118:859–866
Shahidi H, Vottero A, Stratakis CA et al (1999) Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem Biophys Res Commun 254:559–565
Gagliardo R, Chanez P, Vignola AM et al (2000) Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med 162:7–13
Pujols L, Alobid I, Benítez P et al (2008) Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids. Allergy 63:1377–1386
Watanabe S, Suzaki H (2008) Changes of glucocorticoid receptor expression in the nasal polyps of patients with chronic sinusitis following treatment with glucocorticoid. In Vivo 22:37–42
Yu M, Watanabe S, Kudo M, Kanai K, Suzaki H (2009) Glucocorticoid receptor immunoreactivity of eosinophils in nasal polyps. Acta Otolaryngol Suppl 562:95–100
Parnes SM, Chuma AV (2000) Acute effects of antileukotrienes on sinonasal polyposis and sinusitis. Ear Nose Throat J 79(18–20):24–25
Stewart RA, Ram B, Hamilton G, Weiner J, Kane KJ (2008) Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis. Otolaryngol Head Neck Surg 139:682–687
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
An, YH., Hong, SL., Han, D.H. et al. Expression of the cysteinyl leukotriene 1 receptor and glucocorticoid receptor-β in nasal polyps. Eur Arch Otorhinolaryngol 270, 1373–1378 (2013). https://doi.org/10.1007/s00405-012-2239-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-012-2239-5